Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.45 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | NMT2 | O60551 | 1/20 | 0.39 |
| ▸ | NMT1 | P30419 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 2/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 2/20 | 0.36 |
| ▸ | CTSV | O60911 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSH | P09668 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13998248 | 0.84 | SIRT6 (0.57) | SLC6A5SIRT6SIRT1FOLH1TLR2 | |
| SCHEMBL21566740 | 0.84 | SIRT6 (0.57) | SLC6A5SIRT6SIRT1FOLH1TLR2 | |
| SCHEMBL25474945 | 0.84 | NOD1 (0.33) | SLC6A5DPP8DPP9DPP7 | |
| SCHEMBL28609342 | 0.83 | SLC6A5 (0.66) | SLC6A5SIRT6SIRT1NMT2NMT1 | |
| SCHEMBL13271590 | 0.82 | SIRT6 (0.44) | SLC6A5SIRT6SIRT1SLC15A2FOLH1 | |
| SCHEMBL5156017 | 0.80 | HPGDS (0.48) | SLC6A5SIRT6SIRT1SLC15A2FOLH1 | |
| SCHEMBL1455498 | 0.80 | FOLH1 (0.62) | SLC6A5SLC15A2FOLH1 | |
| SCHEMBL20978516 | 0.80 | SIRT6 (0.42) | SLC6A5SIRT6SIRT1FOLH1TLR2 | |
| SCHEMBL32675730 | 0.80 | HPGDS (0.48) | SLC6A5SIRT6SIRT1SLC15A2FOLH1 | |
| SCHEMBL14878853 | 0.80 | SIRT6 (0.42) | SLC6A5SIRT6SIRT1FOLH1TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250019499-A1 | NOVEL CATIONIC POLYPHOSPHAZENE COMPOUND, POLYPHOSPHAZENES-DRUG CONJUGATE COMPOUND AND METHOD FOR PREPARING SAME | CNPHARM CO., LTD. (KR) | 2025-01-16 | — | — | US | disclosed |
| US-11912829-B2 | Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same | CNPHARM CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-20220064384-A1 | NOVEL CATIONIC POLYPHOSPHAZENE COMPOUND, POLYPHOSPHAZENES-DRUG CONJUGATE COMPOUND AND METHOD FOR PREPARING SAME | CNPHARM CO., LTD. (KR) | 2022-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912829-B2 | Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same | PHOSPHO1, DNPEP, PHYKPL | SLC6A5 1095/4885SIRT6 4673/4885SIRT1 4822/4885 |
| US-20250019499-A1 | NOVEL CATIONIC POLYPHOSPHAZENE COMPOUND, POLYPHOSPHAZENES-DRUG CONJUGATE COMPOUND AND METHOD FOR PREPARING SAME | DNPEP, ANPEP, PHOSPHO1 | SLC6A5 1275/4885SIRT6 4617/4885SIRT1 4795/4885 |
| US-20220064384-A1 | NOVEL CATIONIC POLYPHOSPHAZENE COMPOUND, POLYPHOSPHAZENES-DRUG CONJUGATE COMPOUND AND METHOD FOR PREPARING SAME | PHOSPHO1, DNPEP, PHYKPL | SLC6A5 1239/4885SIRT6 4699/4885SIRT1 4843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.